Add to ORKGWe review the available literature on granulocyte-monocyte apheresis for the treatment of inflammatory bowel disease and report the outcome data of a multicenter observational study from the Italian registry for therapeutic apheresis
[Objective] To evaluate the effectiveness and safety of the combination of granulocyte–monocyte aphe...
Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative...
International audienceBACKGROUND AND AIMS: Patients with active, steroid-dependent ulcerative coliti...
We review the available literature on granulocyte-monocyte apheresis for the treatment of inflammato...
The Italian Registry of Therapeutic Apheresis: Granulocyte-Monocyte Apheresis in the Treatment of In...
Leukocytes are thought to play an important role in the pathogenesis of inflammatory bowel diseases;...
Leukocytes are thought to play an important role in the pathogenesis of inflammatory bowel diseases;...
Leukocytes are thought to play an important role in the pathogenesis of inflammatory bowel diseases;...
Leukocytes are thought to play an important role in the pathogenesis of inflammatory bowel diseases;...
Objective. Selective leukocyte apheresis is a new type of non-pharmacological treatment for patients...
Granulocyte monocyte apheresis (GMA) is a non-pharmacological treatment for inflammatory bowel disea...
The etiology of inflammatory bowel disease (IBD) is not completely understood, thus current therapie...
Background/Aims: Patients with active ulcerative colitis (UC) have elevated levels of activated myel...
AIM: To evaluate whether the effectiveness of Granulomonocyto apheresis (GMA), a technique that cons...
Introduction: Inflammatory bowel disease (IBD) is a chronic immune-mediated disease of the gastroint...
[Objective] To evaluate the effectiveness and safety of the combination of granulocyte–monocyte aphe...
Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative...
International audienceBACKGROUND AND AIMS: Patients with active, steroid-dependent ulcerative coliti...
We review the available literature on granulocyte-monocyte apheresis for the treatment of inflammato...
The Italian Registry of Therapeutic Apheresis: Granulocyte-Monocyte Apheresis in the Treatment of In...
Leukocytes are thought to play an important role in the pathogenesis of inflammatory bowel diseases;...
Leukocytes are thought to play an important role in the pathogenesis of inflammatory bowel diseases;...
Leukocytes are thought to play an important role in the pathogenesis of inflammatory bowel diseases;...
Leukocytes are thought to play an important role in the pathogenesis of inflammatory bowel diseases;...
Objective. Selective leukocyte apheresis is a new type of non-pharmacological treatment for patients...
Granulocyte monocyte apheresis (GMA) is a non-pharmacological treatment for inflammatory bowel disea...
The etiology of inflammatory bowel disease (IBD) is not completely understood, thus current therapie...
Background/Aims: Patients with active ulcerative colitis (UC) have elevated levels of activated myel...
AIM: To evaluate whether the effectiveness of Granulomonocyto apheresis (GMA), a technique that cons...
Introduction: Inflammatory bowel disease (IBD) is a chronic immune-mediated disease of the gastroint...
[Objective] To evaluate the effectiveness and safety of the combination of granulocyte–monocyte aphe...
Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative...
International audienceBACKGROUND AND AIMS: Patients with active, steroid-dependent ulcerative coliti...